Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Sensors (Basel) ; 23(16)2023 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-37631720

RESUMEN

Recently, federated learning (FL) has been receiving great attention as an effective machine learning method to avoid the security issue in raw data collection, as well as to distribute the computing load to edge devices. However, even though wireless communication is an essential component for implementing FL in edge networks, there have been few works that analyze the effect of wireless networks on FL. In this paper, we investigate FL in small-cell networks where multiple base stations (BSs) and users are located according to a homogeneous Poisson point process (PPP) with different densities. We comprehensively analyze the effects of geographic node deployment on the model aggregation in FL on the basis of stochastic geometry-based analysis. We derive the closed-form expressions of coverage probability with tractable approximations and discuss the minimum required BS density for achieving a target model aggregation rate in small-cell networks. Our analysis and simulation results provide insightful information for understanding the behaviors of FL in small-cell networks; these can be exploited as a guideline for designing the network facilitating wireless FL.

2.
Eur J Clin Pharmacol ; 78(8): 1217-1225, 2022 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-35657416

RESUMEN

PURPOSE: To conduct a systematic review to identify studies that assessed the association between CYP2C19 polymorphisms and clinical outcomes in peripheral artery disease (PAD) patients who took clopidogrel. METHODS: We systematically searched Ovid EMBASE, PubMed, and Web of Science from November 1997 (inception) to September 2020. We included observational studies evaluating how CYP2C19 polymorphism is associated with clopidogrel's effectiveness and safety among patients with PAD. We extracted relevant information details from eligible studies (e.g., study type, patient population, study outcomes). We used the Risk of Bias in Non-randomized Studies-of Interventions (ROBINS-I) Tool to assess the risk of bias for included observational studies. RESULTS: The outcomes of interest were the effectiveness and safety of clopidogrel. The effectiveness outcomes included clinical ineffectiveness (e.g., restenosis). The safety outcomes included bleeding and death related to the use of clopidogrel. We identified four observational studies with a sample size ranging from 50 to 278. Outcomes and comparison groups of the studies varied. Three studies (75%) had an overall low risk of bias. All included studies demonstrated that carrying CYP2C19 loss of function (LOF) alleles was significantly associated with reduced clinical effectiveness and safety of clopidogrel. CONCLUSIONS: Our systematic review showed an association between CYP2C19 LOF alleles and reduced functions of clopidogrel. The use of CYP2C19 testing in PAD patients prescribed clopidogrel may help improve the clinical outcomes. However, based on the limited evidence, there is a need for randomized clinical trials in PAD patients to test both the effectiveness and safety outcomes of clopidogrel.


Asunto(s)
Clopidogrel , Citocromo P-450 CYP2C19 , Enfermedad Arterial Periférica , Clopidogrel/efectos adversos , Clopidogrel/uso terapéutico , Citocromo P-450 CYP2C19/genética , Genotipo , Humanos , Enfermedad Arterial Periférica/tratamiento farmacológico , Enfermedad Arterial Periférica/genética , Inhibidores de Agregación Plaquetaria/uso terapéutico , Polimorfismo Genético , Resultado del Tratamiento
3.
BMJ Open ; 12(2): e052401, 2022 02 21.
Artículo en Inglés | MEDLINE | ID: mdl-35190423

RESUMEN

OBJECTIVE: To develop a descriptive model of the cognitive processes used to identify and resolve adverse drug reactions (ADRs) from the perspective of healthcare providers in order to inform future informatics efforts SETTING: Inpatient and outpatient care at a tertiary care US Veterans Affairs Medical Center. PARTICIPANTS: Physicians, nurse practitioners and pharmacists who report ADRs. OUTCOMES: Descriptive model and emerging themes from interviews. RESULTS: We conducted critical decision method interviews with 10 physicians and 10 pharmacists. No nurse practitioners submitted ADR incidents. We generated a descriptive model of an ADR decision-making process and analysed emerging themes, categorised into four stages: detection of potential ADR, investigation of the problem's cause, risk/benefit consideration, and plan, action and follow-up. Healthcare professionals (HCPs) relied on several confirmatory or disconfirmatory cues to detect and investigate potential ADRs. Evaluating risks and benefits of related medications played an essential role in HCPs' pursuits of solutions CONCLUSIONS: This study provides an illustrative model of how HCPs detect problems and make decisions regarding ADRs. The design of supporting technology for potential ADR problems should align with HCPs' real-world cognitive strategies, to assist fully in detecting and preventing ADRs for patients.


Asunto(s)
Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Veteranos , Sistemas de Registro de Reacción Adversa a Medicamentos , Atención Ambulatoria , Cognición , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/prevención & control , Humanos , Pacientes Internos , Farmacéuticos
4.
BMJ Case Rep ; 12(5)2019 May 31.
Artículo en Inglés | MEDLINE | ID: mdl-31154343

RESUMEN

Hypercalcaemia is a rare but potentially life-threatening consequence of malignancies. Solid cancers, such as lymphomas, increase serum calcium primarily through parathyroid hormone-related protein or ectopic production of 1alpha-hydroxylase. We present a case of 56-year-old woman with Sjogren's syndrome and psoriasis in the setting of chronic methotrexate (MTX) use who developed worsening hypercalcaemia and symptoms suggestive of lymphoma. Pathology results diagnosed her with MTX-induced iatrogenic immunodeficiency-associated lymphoproliferative disorder (LPD). This case reminds clinicians that chronic MTX use is associated with LPDs and can ultimately lead to hypercalcaemia. The patient's MTX and other immunosuppressive medications were stopped, and her calcium corrected with fluids and calcitonin. At her 8-month follow-up postdischarge, the patient was asymptomatic with normal laboratory results and in partial clinical remission.


Asunto(s)
Fármacos Dermatológicos/efectos adversos , Hipercalcemia/diagnóstico , Trastornos Linfoproliferativos/diagnóstico , Metotrexato/efectos adversos , Psoriasis , Síndrome de Sjögren , Diagnóstico Diferencial , Femenino , Humanos , Hipercalcemia/inducido químicamente , Hipercalcemia/etiología , Síndromes de Inmunodeficiencia/inducido químicamente , Síndromes de Inmunodeficiencia/diagnóstico , Síndromes de Inmunodeficiencia/etiología , Trastornos Linfoproliferativos/inducido químicamente , Trastornos Linfoproliferativos/etiología , Persona de Mediana Edad
5.
BMJ Case Rep ; 20182018 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-29386211

RESUMEN

Neurofibromatosis type 1 (NF1)-related lung disease is a rare but increasingly recognised, high morbidity associated feature of the condition. We present a 48-year-old male patient with NF1, who was initially admitted for a subarachnoid haemorrhage requiring aneurysmal coil embolisation. During his recovery, he developed a left-sided pneumothorax requiring chest tube placement followed by concerns for re-expansion pulmonary oedema requiring intubation. Subsequently, the patient also developed a right-sided pneumothorax requiring additional chest tube placement but did not develop right-sided pulmonary oedema. During his hospitalisation, the patient also exemplified other important NF1-related pathophysiology including pheochromocytoma, cerebrovascular abnormalities and cardiovascular manifestations. Due to his multiple comorbidities and poor prognosis, we held a goals of care discussion with the patient's mother, and with her agreement, the patient underwent compassionate withdrawal of artificial life support.


Asunto(s)
Cuidados para Prolongación de la Vida , Pulmón/diagnóstico por imagen , Neurofibromatosis 1/fisiopatología , Neumotórax/diagnóstico por imagen , Edema Pulmonar/diagnóstico por imagen , Accidente Cerebrovascular/fisiopatología , Hemorragia Subaracnoidea/fisiopatología , Privación de Tratamiento , Neoplasias de las Glándulas Suprarrenales , Tubos Torácicos , Comorbilidad , Toma de Decisiones , Progresión de la Enfermedad , Embolización Terapéutica , Humanos , Intubación , Masculino , Persona de Mediana Edad , Neurofibromatosis 1/complicaciones , Neurofibromatosis 1/terapia , Feocromocitoma , Neumotórax/fisiopatología , Neumotórax/terapia , Pronóstico , Edema Pulmonar/fisiopatología , Edema Pulmonar/terapia , Accidente Cerebrovascular/diagnóstico por imagen , Accidente Cerebrovascular/etiología , Accidente Cerebrovascular/terapia , Hemorragia Subaracnoidea/diagnóstico por imagen , Hemorragia Subaracnoidea/terapia , Cuidado Terminal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA